Dry Eye Disease

FDA warnings about potentially contaminated over-the-counter eye drops topped the news on Healio Optometry this year.

Today’s presbyopes lead increasingly digital lifestyles, with extensive attention to screens, which research shows can cause decreased and incomplete blinking, tear film instability and lead to the development of dry eye disease.

The FDA issued a complete response letter regarding the new drug application for reproxalap for the treatment of dry eye disease, according to a press release from Aldeyra Therapeutics.

There is simply no other way to put this: Miebo is magic.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

Healio’s top items from this year’s American Academy of Ophthalmology meeting included pearls for navigating secondary dry eye disease as well as data for low-dose atropine as a myopia treatment in children aged 3 to 17 years.

SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Scott D. Barnes, MD, chief medical officer of STAAR Surgical, discusses how the EVO ICL is still a new and disruptive product for vision correction.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, John D. Sheppard, MD, MMSc, discusses Miebo for the treatment of dry eye disease.

SAN FRANCISCO — Dry eye is an umbrella term that covers multiple etiologies and different presentations.

In-office procedures are an integral part of modern dry eye disease management for general practices and specialty clinics alike.